Prasad Kulkarni - Serum Institute of India Limited

基本信息

Career Trajectory

Bio

Dr. Prasad Kulkarni is a clinical pharmacologist with several years experience in new drug development, clinical research, pharmacovigilance, regulatory practices and medical advice. He works at the Serum Institute of India Ltd which is the largest vaccine manufacturer in the world in terms of doses supplied. He has more than 50 publications in journals like the New England Journal of Medicine, Clinical Infectious Diseases, Vaccine, etc. and has written three book chapters.

Research Interests

Papers共 127 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Immunogenicity of a Reduced-Dose Inactivated Poliovirus Vaccine Versus a Full-Dose Inactivated Poliovirus Vaccine in Infants in Bangladesh: a Double-Blind, Non-Inferiority, Randomised, Controlled, Phase 3 Trial

Prasad S Kulkarni,Khalequ Zaman, Sajjad A Desai, Sandesh Bharati, Doli R Goswami, Amina T Sharmeen, Sohel Rana,Warda Haque, Ashish Khandelwal, Satyaprasad Manney, Parikshit Tyagi,Sunil Gairola, Jagdish K Zade,Sambhaji S Pisal, Rajeev M Dhere, Cyrus S Poonawalla, Chris Lamberigts, Varsha Parulekar, Anirudha Vyankatesh Potey

The Lancet Infectious diseases (2025)

Cited0Views0WOSBibtex

Safety and Immunogenicity of a Pentavalent Meningococcal Conjugate Vaccine Targeting Serogroups A, C, W, Y, and X when Co-Administered with Routine Childhood Vaccines at Ages 9 Months and 15 Months in Mali: a Single-Centre, Double-Blind, Randomised, Controlled, Phase 3, Non-Inferiority Trial

Fatoumata Diallo,Fadima C Haidara,Milagritos D Tapia, Clara P Dominguez Islas,Mark R Alderson,William P Hausdorff,Lionel Martellet,Nancy Hosken,Dhananjay Kapse,Prasad S Kulkarni, Kelly Townsend-Payne, Francesca Vanni,Christine M Posavad,Samba O Sow,Karen L Kotloff,Wilbur H Chen

sciencedirect（2025）

Cited0Views0WOSBibtex

Safety and Immunogenicity of a Pentavalent Meningococcal Conjugate Vaccine Versus a Quadrivalent Meningococcal Conjugate Vaccine in Adults in India: an Observer-Blind, Randomised, Active-Controlled, Phase 2/3 Study

Prasad S Kulkarni,Anand Kawade,Sunil Kohli,Renuka Munshi,Chetna Maliye, Nithya J Gogtay,Ravish H S,Kiranjit Singh, K Vengadakrishnan,Sandeep Kumar Panigrahi,Jyotiranjan Sahoo,Ashish Bavdekar,B S Garg,Abhishek Raut, Jeffrey P Raj, Unnati Saxena, Vijaya L Chaudhari,Rakesh Patil,Epari Venkatarao, Nitu Kumari

The Lancet Infectious Diseases (2024)

Cited0Views0WOSBibtex

Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal Adenocarcinoma

Prerana Jha, Ruma Pengal,Minit Shah,Prasad S. Kulkarni,Rohit Mishra,Nandini Menon, Narendranath Vikkath,Santosh Menon,Venkataramanan Ramachandran,Gagan Prakash,Vanita Noronha,K. Prabhash,Prashant Kumar

Genes Chromosomes and Cancerno. 6 (2024)

Cited0Views0Bibtex

Immunogenicity and Safety of Meningococcal ACWYX Conjugate Vaccine when Coadministered with Routine Childhood Vaccines at 9-Months and 15-Months of Age: A Randomised, Controlled, Phase 3, Non-Inferiority Trial

Fatoumata Diallo,Fadima Haidara,Milagritos D. Tapia,Souleymane Diakite, Alfousseny Toure,Youssouf Traore,Awa Traore,Mamoudou Kodio,Clara Dominguez Islas, Fleesie Hubbard, William Hausdorff,Lionel Martellet,Nancy Hosken,Mark Alderson,Dhananjay Kapse,Prasad S. Kulkarni,Kelly Townsend-Payne, Francesca Vanni,Monica M. Farley, Brett Hanscom,Clifton Kelly,Christine M. Posavad,Samba O. Sow,Karen L. Kotloff,Wilbur Chen

crossref（2024）

Cited0Views0Bibtex

The Safety and Immunogenicity of a Bivalent Conjugate Vaccine Against Salmonella Enterica Typhi and Paratyphi A in Healthy Indian Adults: a Phase 1, Randomised, Active-Controlled, Double-Blind Trial

Prasad S. Kulkarni, Anirudha Vyankatesh Potey,Sandesh Bharati, Anil Kunhihitlu, Bharath Narasimha, Sindhu Yallapa,Abhijeet Dharmadhikari, Vinay Gavade, Chandrashekhar Kamat,Asha Mallya,Annamraju Sarma,Sunil Goel,Sambhaji S. Pisal,Cyrus S. Poonawalla, Rajaram Venkatesan,Elizabeth Jones,Amy Flaxman,Young Chan Kim,Andrew J. Pollard

LANCETno. 10436 (2024): 1554-1562

Cited2Views0WOSBibtex

An Observer-Blind, Randomised, Placebo-Controlled, Phase 1, Single Ascending Dose Study of Dengue Monoclonal Antibody in Healthy Adults in Australia

Bhagwat Gunale, Nicholas Farinola, Chandrashekhar Kamat,Cyrus S. Poonawalla,Sambhaji S. Pisal,Rajeev M. Dhere, Claire Miller,Prasad S. Kulkarni

The Lancet Infectious Diseasesno. 6 (2024): 639-649

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn